Related Experiment Video
Updated: Jun 17, 2026

In Vitro Generation of Heart Field-specific Cardiac Progenitor Cells
Published on: July 3, 2019
CD117-positive cells of the heart: progenitor cells or mast cells?
1Department of Pathology, School of Basic Medical Sciences, Peking University, Beijing, China.
Insights
Most CD117-positive cells in the human heart are mast cells, not cardiac stem cells. This finding challenges the use of CD117 as a reliable marker for cardiac progenitor cells in heart repair research.
Area of Science:
- Cardiovascular Biology
- Stem Cell Research
- Immunology
Background:
- Human cardiac stem/progenitor cells are crucial for heart injury repair.
- CD117 is commonly used to identify cardiac stem/progenitor cells.
- Cardiac mast cells also express CD117, potentially confounding cell identification.
Purpose of the Study:
- To investigate the relationship between CD117-positive cells and mast cells in the human heart.
- To determine if CD117 is a reliable marker for cardiac progenitor cells.
- To clarify the identity of CD117-positive cells in cardiac tissue.
Main Methods:
- Analysis of human left ventricle samples (n=5 patients, ages 1 week-75 years).
- Immunohistochemical staining for CD117, tryptase, toluidine blue, thionine, and CD45.
- Quantification of CD117-positive cells and their co-localization with mast cell markers.
Main Results:
- 85-100% of CD117-positive cells in the human heart were identified as mast cells.
- Mast cells exhibited weak to moderate CD45 immunostaining.
- CD117-positive/CD45-dim/moderate cells previously identified as putative cardiac progenitors are likely mast cells.
Conclusions:
- The majority of CD117-positive cells in the human heart are mast cells.
- CD117 is not a specific marker for cardiac progenitor cells.
- This finding has significant implications for stem cell research in cardiac repair.
Abstract:
Human cardiac stem/progenitor cells and their potential for repair of heart injury are a current hot topic of research. CD117 has been used frequently as a marker for identification of stem/progenitor cells in the heart. However, cardiac mast cells, which are also CD117(+), have not been excluded by credible means when selecting putative cardiac progenitors by using CD117 as a marker. We evaluated the relationship between CD117(+) cells and mast cells in the left ventricle of human hearts (n=5 patients, ages 1 week-75 years) with the well-established mast cell markers tryptase, toluidine blue, and thionine. A large number (85-100%) of CD117(+) cells in the human heart were specifically identified as mast cells. In addition, mast cells showed weak or moderate CD45 immunostaining signals. These results indicate that the majority of CD117(+) cells in the heart are mast cells and that these cells are distinctly positive for CD45, although staining was weak or moderate. These results strongly suggest that the newly reported CD117(+)/CD45(dim/moderate) putative cardiac progenitor cells are mast cells. The significance of this observation in stem cell research of the heart is discussed.
Related Concept Videos
Differentiation of Common Myeloid Progenitor Cells
Multipotency of Hematopoietic Stem Cells
Production of Formed Elements
Most HSCs commit to...

